Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Name: Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics
SKU: 3342
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 2 Articles Tags: cellular-resilience, husseini-k-manji, medworks-media, mood-disorders, neuroplasticity, psychopharmacology-bulletin, ronald-s-duman

Description

Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Description

Husseini K. Manji, MD, FRCPC

TRANSLATIONAL NEUROSCIENCE

Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Husseini K. Manji,MD, FRCPC and Ronald S. Duman, PhD

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Assessment of Anxiety in Clinical Trials with Depressed Patients

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Description

Husseini K. Manji, MD, FRCPC

TRANSLATIONAL NEUROSCIENCE

Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Husseini K. Manji,MD, FRCPC and Ronald S. Duman, PhD

Related products

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Assessment of Anxiety in Clinical Trials with Depressed Patients

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3